News Releases

Date Title
11/25/2013 Summary ToggleEnanta Pharmaceuticals Reports Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2013
11/25/2013 Summary ToggleEnanta Pharmaceuticals Announces the Appointment of Bruce L.A. Carter, Ph.D. to Board of Directors
11/18/2013 Summary ToggleEnanta Pharmaceuticals Announces 96 Percent SVR12 in SAPPHIRE-I Study
11/15/2013 Summary ToggleEnanta Pharmaceuticals to Host Conference Call to Discuss Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2013
11/06/2013 Summary ToggleEnanta Pharmaceuticals to Present at the 2013 Credit Suisse Healthcare Conference
11/03/2013 Summary ToggleNew GT-1b Data from ABT-450 Containing Regimen Being Presented at The Liver Meeting
10/01/2013 Summary ToggleEnanta Announces New Data on ABT-450 Regimens to be Presented at The Liver Meeting (AASLD)
09/03/2013 Summary ToggleEnanta Pharmaceuticals Announces National Institute of Allergy and Infectious Diseases (NIAID) Will Fund Further Development of a Novel Bicyclolide
08/28/2013 Summary ToggleEnanta Pharmaceuticals to Present at Upcoming Investor Conferences
08/12/2013 Summary ToggleEnanta Pharmaceuticals Reports Financial Results for the Third Fiscal Quarter and Nine Months Ended June 30, 2013